Steffen Leth
Impact in
- Virology top 1%
- HIV Research and Treatment
- Infectious Diseases top 5%
- HIV/AIDS drug development and treatment
- HIV/AIDS Research and Interventions
- COVID-19 Clinical Research Studies
Papers in
-
- HIV/AIDS Research and Interventions 8
- COVID-19 Clinical Research Studies 7
- HIV/AIDS drug development and treatment 6
- Neurology 13
- Long-Term Effects of COVID-19 13
- Co-authors
- Lars Østergaard (15 shared papers)Ole S. Søgaard (9 shared papers)Martin Tolstrup (7 shared papers)Rikke Olesen (5 shared papers)Paul W. Denton (6 shared papers)Maja A. Sommerfelt (3 shared papers)Sara Konstantin Nissen (3 shared papers)Kim Krogsgaard (3 shared papers)
- Journals
- Open Forum Infectious Diseases (3 papers)AIDS (3 papers)Infectious Diseases (2 papers)Journal of Medical Virology (2 papers)The Lancet Regional Health - Europe (2 papers)
- Partner nations
- DenmarkUnited StatesSwitzerland
In The Last Decade
Steffen Leth
39 papers receiving 939 citations
Steffen Leth's Hit Papers
Peers
Comparison fields: 5 of 91
- Virology 514
- Infectious Diseases 461
- Neurology 208
- Critical Care and Intensive Care Medicine 57
- Immunology 190
Countries citing papers authored by Steffen Leth
This map shows the geographic impact of Steffen Leth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steffen Leth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steffen Leth more than expected).
Fields of papers citing papers by Steffen Leth
This network shows the impact of papers produced by Steffen Leth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steffen Leth. The network helps show where Steffen Leth may publish in the future.
Co-authors
The 25 scholars most cited alongside Steffen Leth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 41 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo Hit paper breakdown → | 2015 | 379 |
| 2 | 2016 | 128 | |
| 3 | 2021 | 58 | |
| 4 | 2012 | 48 | |
| 5 | 2021 | 46 | |
| 6 | 2022 | 29 | |
| 7 | 2017 | 26 | |
| 8 | 2012 | 26 | |
| 9 | 2021 | 24 | |
| 10 | 2022 | 23 | |
| 11 | 2022 | 22 | |
| 12 | 2022 | 16 | |
| 13 | 2022 | 11 | |
| 14 | 2015 | 10 | |
| 15 | 2016 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2014 | 8 | |
| 18 | 2023 | 7 | |
| 19 | 2023 | 7 | |
| 20 | 2022 | 7 |
About Steffen Leth
Steffen Leth is a scholar working on Infectious Diseases, Neurology, Critical Care and Intensive Care Medicine, Epidemiology and Virology, having authored 41 papers that have together received 950 indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (13 papers), HIV/AIDS Research and Interventions (8 papers), COVID-19 Clinical Research Studies (7 papers), Intensive Care Unit Cognitive Disorders (6 papers), HIV Research and Treatment (6 papers), HIV/AIDS drug development and treatment (6 papers), HIV-related health complications and treatments (5 papers) and COVID-19 and Mental Health (4 papers). The work is most often cited by research in Virology (514 citations), Infectious Diseases (461 citations), Neurology (208 citations), Critical Care and Intensive Care Medicine (57 citations) and Immunology (190 citations). Steffen Leth has collaborated with scholars based in Denmark, United States and Switzerland. Frequent co-authors include Lars Østergaard, Ole S. Søgaard, Martin Tolstrup, Rikke Olesen, Paul W. Denton, Maja A. Sommerfelt, Sara Konstantin Nissen, Kim Krogsgaard, Mariane Høgsbjerg Schleimann and Thomas A. Rasmussen. Their work appears in journals such as Open Forum Infectious Diseases, AIDS, Infectious Diseases, Journal of Medical Virology and The Lancet Regional Health - Europe.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.